Literature DB >> 32383085

Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.

Ramsey M Wehbe1, Preeti Kansal1, Thomas A Holly2.   

Abstract

Cardiac scintigraphy has emerged as a key diagnostic test for transthyretin cardiac amyloidosis (ATTR-CA). However, there are potential limitations and pitfalls in the interpretation of cardiac scintigraphy for ATTR-CA that are worth noting. We present here a series of three cases which illustrate some of these important principles.

Entities:  

Keywords:  Amyloid heart disease; SPECT; heart failure; image interpretation; multimodality; others

Mesh：

Substances：

Year:  2020        PMID： 32383085     DOI： 10.1007/s12350-020-02094-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  11 in total

1.  Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis.

Authors:  Simone Longhi; Massimiliano Lorenzini; Christian Gagliardi; Agnese Milandri; Antonio Marzocchi; Cinzia Marrozzini; Francesco Saia; Paolo Ortolani; Elena Biagini; Pier Luigi Guidalotti; Ornella Leone; Claudio Rapezzi
Journal:  JACC Cardiovasc Imaging       Date:  2015-07-15

2.  Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.

Authors:  Youssef Bennani Smires; Gérard Victor; David Ribes; Matthieu Berry; Thomas Cognet; Simon Méjean; Antoine Huart; Murielle Roussel; Antoine Petermann; Jérôme Roncalli; Didier Carrié; Hervé Rousseau; Isabelle Berry; Dominique Chauveau; Michel Galinier; Olivier Lairez
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-30       Impact factor: 2.357

3.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

Authors:  Adam Castano; Muhammad Haq; David L Narotsky; Jeff Goldsmith; Richard L Weinberg; Rachelle Morgenstern; Ted Pozniakoff; Frederick L Ruberg; Edward J Miller; John L Berk; Angela Dispenzieri; Martha Grogan; Geoffrey Johnson; Sabahat Bokhari; Mathew S Maurer
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

4.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors:  Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

Review 5.  Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.

Authors:  Ronald M Witteles; Sabahat Bokhari; Thibaud Damy; Perry M Elliott; Rodney H Falk; Nowell M Fine; Mariana Gospodinova; Laura Obici; Claudio Rapezzi; Pablo Garcia-Pavia
Journal:  JACC Heart Fail       Date:  2019-07-10       Impact factor: 12.035

6.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

7.  Prognostic Significance of Occult Transthyretin Cardiac Amyloidosis in Patients With Severe Aortic Stenosis Undergoing Surgical Aortic Valve Replacement: An Unrecognized Disease Modifier.

Authors:  Jun Koyama
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

8.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

9.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

10.  Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT.

Authors:  Ariana Nodoushani; Mohammed Samir El-Sady; Mi-Ae Park; Gloria L Castilloveitia; Rodney H Falk; Marcelo F Di Carli; Marie Foley Kijewski; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2019-11-22       Impact factor: 3.872
View more
  4 in total

1.  Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.

Authors:  Talal Asif; Javier Gomez; Vasvi Singh; Rami Doukky; Arlet Nedeltcheva; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2020-09-08       Impact factor: 5.952

2.  Incidental detection of ATTR cardiac amyloidosis.

Authors:  Jessica A Quaggin-Smith; Ramsey M Wehbe; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2021-01-10       Impact factor: 3.872

3.  A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.

Authors:  Mrinali Shetty
Journal:  J Nucl Cardiol       Date:  2021-03-02       Impact factor: 5.952

Review 4.  99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.

Authors:  Nobuhiro Tahara; Olivier Lairez; Jin Endo; Atsushi Okada; Mitsuharu Ueda; Tomonori Ishii; Yoshinobu Kitano; Hahn-Ey Lee; Eleonora Russo; Toru Kubo
Journal:  ESC Heart Fail       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.